Search

everythinglearnresearchcommunity

for

Search:↓

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

DNCB is highly effective for treating alopecia areata with minimal long-term side effects.

Acute leukemias with the Philadelphia chromosome may be biphenotypic, and identifying this is important for proper treatment.

Combining platelet concentrates with stem cells improves regenerative therapies.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.

RADA16 is a promising material for tissue repair and regenerative medicine but needs improvement in strength and cost.

MEGA PROTAC improves prediction and ranking of protein complexes better than existing methods.

PAD3 plays a key role in hair and skin protein structure and may be linked to skin diseases.

New mouse models of Pemphigus show severe symptoms and need better treatments.

CCCA may involve the PD1/PDL1 pathway and increased caspase 3, leading to permanent hair loss.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

Antibody treatments show promise for hair loss but need more research.

A new method improves platelet testing for heart disease patients.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Using a combination of AMD3100 and FK506 can speed up and improve wound healing in diabetic rats.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Scientists improved an enzyme to better produce a hair growth-promoting chemical from an immunosuppressant.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

PTH-CBD agonists may help regrow hair after chemotherapy.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.